Tempus Wealth Planning’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
Tempus Wealth Planning's BMY Position: Q2 2026 in Review
Tempus Wealth Planning increased its Bristol-Myers Squibb (BMY) stake by 11% in Q2 2026, buying an estimated $88.9K and bringing the position to 15,761 shares worth $908K. The position accounts for 0.18% of the portfolio, ranked #137.
Tempus Wealth Planning first reported a position in BMY in Q4 2019 and has held it in 27 quarters since. 936 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Tempus Wealth Planning held 15,761 shares of Bristol-Myers Squibb worth $908K as of Q2 2026.
- Tempus Wealth Planning bought 1,548 Bristol-Myers Squibb shares in Q2 2026, an estimated $88.9K.
- Bristol-Myers Squibb made up 0.18% of Tempus Wealth Planning's portfolio in Q2 2026, its #137 holding.
- Tempus Wealth Planning first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 27 quarters since.
- 936 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Tempus Wealth Planning's 13F filing for Q2 2026, filed 22 Jul 2026.